SCHEMBL7609565

SCHEMBL7609565

C[C@H](NC(=O)Cc1ccccc1)C(=O)N[C@H]1N=C(c2ccccc2)c2cc(Cl)ccc2N(C)C1=O

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 2/20 0.71
PSEN2 P49810 2/20 0.71
APH1B Q8WW43 2/20 0.71
NCSTN Q92542 2/20 0.71
APH1A Q96BI3 2/20 0.71
PSENEN Q9NZ42 2/20 0.71
GSAP A4D1B5 1/20 0.71
NOTCH1 P46531 1/20 0.60
RBPJ Q06330 1/20 0.60
CCKBR P32239 10/20 0.57
CCKAR P32238 2/20 0.56
KCNH2 Q12809 1/20 0.56
LMNA P02545 1/20 0.55
OPRK1 P41145 1/20 0.55
PDE3A Q14432 1/20 0.55
SCN9A Q15858 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4986766 1.00 PSEN1 (0.71) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4982581 0.93 PSEN1 (0.74) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4417214 0.93 PSEN1 (0.84) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4995607 0.92 PSEN1 (0.62) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4989354 0.91 NOTCH1 (0.63) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4995803 0.91 PSEN1 (0.77) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4995599 0.90 PSEN1 (0.77) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4993718 0.90 PSEN1 (0.62) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4993605 0.89 PSEN1 (0.84) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL28740943 0.89 PSEN1 (0.84) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020045747-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds WU JING (US) 2002-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045747-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds BACE1, APP, BACE2 PSEN1 6/4885PSEN2 9/4885APH1B 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.